The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

Kim, Y. H., Shim, J., Tsai, C. T., Wang, C. C., Vilela, G., Muengtaweepongsa, S., … Camm, A. J. (2019, June 1). The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. Chest. Elsevier Inc. https://doi.org/10.1016/j.chest.2019.03.036